Illustration of a clinic building (not a photo of the practice)
Illustration

Mark M. Tungesvik, MD

Hematology/oncology in Columbia, MO

  • Enrolled in Medicare
  • Accepts Medicare assignment
  • 25 years since graduation
  • Public record — not managed by the clinician

About Dr. Mark Tungesvik

Dr. Mark Tungesvik is a physician specializing in hematology/oncology practicing in Columbia, MO, a graduate of University of Missouri, Columbia School of Medicine (2001). Affiliated with Boone Hospital Center, Fitzgibbon Hospital. Treated 926 Medicare patients in 2024.

Provider details

SpecialtyHematology/oncologyOther hematology/oncology doctors in Columbia
CredentialsMD
EducationUniversity of Missouri, Columbia School of Medicine, 2001CMS Doctors and Clinicians
GenderMale
NPI number1497723472National Provider Identifier (CMS NPPES), issued March 2006
MedicareEnrolled in Medicare; accepts Medicare assignment (the Medicare-approved amount as full payment)CMS Doctors and Clinicians

Dr. Mark Tungesvik's specialties and state licenses

  • Hematology & Oncology Primary
    License: MO 2005004970

As reported by the clinician to the NPPES registry. Confirm a license and any disciplinary history with the state medical or licensing board.

Where Dr. Mark Tungesvik practices

  • Practice address 1705 E Broadway, Suite 100, Columbia, MO 65201 Directions

Addresses from CMS Doctors and Clinicians (Medicare enrollment). Call before visiting: a clinician may not see patients at every listed address.

Hospital affiliations of Dr. Mark Tungesvik

  • Boone Hospital CenterHospital · Columbia, MO
  • Fitzgibbon HospitalHospital · Marshall, MO

CMS Facility Affiliation data: facilities where the clinician bills Medicare.

Dr. Mark Tungesvik's Medicare quality score (MIPS 2024)

83/100final MIPS score
60.7quality
100promoting interoperability
40improvement activities
82.7cost

The Merit-based Incentive Payment System scores clinicians who bill Medicare. Reported as subgroup. Source: CMS Care Compare, PY 2024 clinician public reporting.

Dr. Mark Tungesvik's Medicare patients and services (2024)

926Medicare patients
194,394services billed
75average patient age
59%women

Most frequent services

ServiceTimesAvg. Medicare allowed
Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more544$116.73
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's437$15.36
Administration of chemotherapy into vein, 1 hour or less378$109.71
Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more335$82.93
Injection of additional new drug or substance into vein321$13.34
Injection of drug or substance under skin or into muscle245$12.83
Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less183$24.42
Ct scan of chest with contrast118$106.10

Common conditions among these patients

  • High blood pressure75%
  • High cholesterol68%
  • Cancer56%
  • Arthritis44%
  • Diabetes31%
  • Ischemic heart disease27%

Medicare Part B fee-for-service claims only (CMS Medicare Physician & Other Practitioners, 2024). Patients with private insurance or Medicare Advantage are not counted; small counts are suppressed by CMS. This describes the patients, not the quality of care.

Payments from drug and device companies to Dr. Mark Tungesvik (2025)

$2,946.23 in 138 general payments reported in 2025.

TypePaymentsAmount
Food and beverage130$2,441.73
Education8$504.50

Paying companies: AbbVie Inc. ($308.89), Daiichi Sankyo Inc. ($301.37), E.R. Squibb & Sons, L.L.C. ($285.75), Pfizer Inc. ($208.90), NOVARTIS PHARMACEUTICALS CORPORATION ($197.59), Merck Sharp & Dohme LLC ($186.17).

Reported by companies under the federal Open Payments program (CMS, program year 2025). A payment, such as a meal at an educational event, does not mean wrongdoing; clinicians can dispute records with CMS.

Questions about Dr. Mark Tungesvik

What kind of clinician is Dr. Mark Tungesvik?

Dr. Mark Tungesvik is listed as a physician specializing in hematology/oncology.

Where does Dr. Mark Tungesvik practice?

The main practice address at 1705 E Broadway, Suite 100, Columbia, MO 65201.

What is the NPI number of Dr. Mark Tungesvik?

The National Provider Identifier is 1497723472.

Does Dr. Mark Tungesvik accept Medicare?

Yes. CMS lists this clinician as accepting Medicare assignment. Confirm your plan with the office.

Which hospitals is Dr. Mark Tungesvik affiliated with?

Boone Hospital Center, Fitzgibbon Hospital.

Where did Dr. Mark Tungesvik go to medical school?

University of Missouri, Columbia School of Medicine, graduating in 2001.

Where this information comes from

CMS Doctors and CliniciansName, specialty, education, Medicare enrollment and practice addresses.Centers for Medicare & Medicaid Services, national downloadable file (2026)
NPPES NPI registryNPI, specialties (taxonomy) and state licenses.CMS National Plan and Provider Enumeration System; record updated 2026-07-28
Facility affiliationsHospitals and other facilities.CMS Doctors and Clinicians facility affiliation file; names from CMS Provider of Services
Medicare utilizationPatients, services and conditions.CMS Medicare Physician & Other Practitioners, 2024
MIPSQuality payment program scores.CMS clinician public reporting, PY 2024
Open PaymentsPayments from drug and device companies.CMS Open Payments, program year 2025

Information is public record and may lag behind changes. Clinicians update it through NPPES and Medicare PECOS. See something wrong? Tell us.

0 clinics selected Compare